Risk factors for hepatitis C virus infection in United States blood donors
β Scribed by Associate Professor Edward L. Murphy; Stephen M. Bryzman; Simone A. Glynn; Dannie I. Ameti; Ruth A. Thomson; Alan E. Williams; Catharie C. Nass; Helen E. Ownby; George B. Schreiber; Fanhui Kong; Keith R. Neal; George J. Nemo
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 108 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Sera from 62 hepatitis C virus (HCV)-infected Swedish blood donors were tested by a nested polymerase chain reaction using primers targeting the 5Π-noncoding region of the GB virus-C/ hepatitis G (GBV-C/HGV) genome and an enzyme-linked immunosorbent assay that detects antibodies to the envelope prot
Chronic hepatitis C virus (HCV) infection affects approximately 3 million people in the United States and places tremendous demands on the health care system. As many observers have predicted, the disease burden continues to grow as the infected population ages. In this study, we analyzed inpatient
RNAs of GB virus C (GBV-C) and hepatitis C virus (HCV) were sought by reverse-transcription polymerase chain reaction with nested primers deduced from the 5Π untranslated region: 79 patients on maintenance hemodialysis, 205 commercial blood donors, and 205 voluntary donors in Beijing were studied. G
## Abstract DOI 10.1002/cncr.11440
## Abstract ## BACKGROUND Hepatic steatosis is one of the histopathologic features of chronic hepatitis C. It was reported recently that the expression of hepatitis C virus (HCV) core protein in transgenic mice induced hepatocellular carcinoma (HCC) in association with steatosis. The objective of